Privosegtor is advancing in the registrational PIONEER program across 2 key optic neuropathies, representing an unaddressed potential market of $7 billion in the U.S. Privosegtor achieved an average ...

Gene therapy with voretigene neparvovec-rzyl partially restores geniculostriate pathway function in LCA2 patients, improving visual processing. Initial LCA2 pathology shifts visual processing from the ...

New research reveals people with visual snow syndrome experience heightened face pareidolia, mistaking everyday objects for ...

Each year, thousands of stroke survivors are left with hemianopia, a condition that causes loss of half of their visual field (the “vertical midline”). Hemianopia severely affects daily activities ...

Diseases that affect the retina, the light-sensitive layer at the back of the eye, are a significant cause of visual impairment and blindness. Gene therapy holds promise for treating some of these ...

For generations, adults with amblyopia were told their vision loss was permanent, a childhood problem that medicine could not meaningfully reverse later in life. A new wave of research from MIT and ...

Mirror box therapy was initially developed by V. S. Ramachandran. The purpose of this new medical device was to try to reduce what was described as “phantom limb pain.” Mirror box therapy is defined ...

Scientists in the UK have successfully used gene therapy to restore some vision to legally blind children with an inherited retinal condition. All 11 children in the clinical trial saw improvements ...

After traumatic brain injury (TBI), some patients may recover completely, while others retain severe disabilities. Accurately ...

Researchers compared a traditional Chinese medicine, Yueju Pill, with a standard antidepressant and found both reduced ...